Related Experiment Video
Updated: May 30, 2026
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods
J Prades1, J A Espinàs, R Font
1Catalonian Cancer Plan, Duran i Reynals Hospital, Av. Gran Via de l'Hospitalet 199-203, Hospitalet de Llobregat, Barcelona 08908, Spain.
British Journal of Cancer
|August 11, 2011
Summary
The Cancer Fast-track Programme improved diagnosis and treatment times for breast, colorectal, and lung cancer patients in Catalonia. It clarified patient pathways between primary and specialized care.
Area of Science:
- Oncology
- Public Health
- Healthcare Management
Background:
- Initiated in Catalonia, Spain, the Cancer Fast-track Programme aimed to shorten the time from cancer suspicion to treatment.
- Focus areas included breast, colorectal, and lung cancers.
Purpose of the Study:
- To analyze the implementation and effectiveness of the Cancer Fast-track Programme.
- To evaluate changes in diagnostic and treatment timelines.
Main Methods:
- Quantitative analysis using hospital-generated data on seven fast-track indicators (2006-2009).
- Qualitative study involving 83 semi-structured interviews with healthcare professionals and administrators.
Main Results:
- Approximately 50% of new breast, lung, and colorectal cancer cases utilized the fast-track system.
- In 2009, mean times from primary care suspicion to treatment initiation were 32 days (breast), 30 days (colorectal), and 37 days (lung).
- General practitioners altered practices to minimize delays; hospitals employed diverse implementation strategies for sustainability.
Conclusions:
- The programme accelerated diagnostic assessment and treatment initiation for suspected cancer patients.
- It enhanced clarity and efficiency in patient pathways between primary and specialized care settings.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...